Anna Falk
Papers
2
Total Citations
70
H-Index
2
About
Anna Falk is a neuroscientist whose research sits at the intersection of stem cell biology and drug discovery, with a particular focus on human neural stem cells and their applications in high-throughput screening platforms. Her work has made significant contributions to the development of scalable, reproducible cell-based systems that can be deployed in pharmaceutical and biomedical research contexts. Falk's most influential contribution, cited 47 times, demonstrated that human induced pluripotent stem cell–derived neuroepithelial-like stem cells could be cultured at large scale and used in automated medium-throughput chemical screens — a landmark advance in making iPSC-derived neural models practically viable for drug discovery pipelines. Complementing this, her 2011 work established non-immortalized human neural stem cells as a robust and scalable assay platform, garnering 23 citations and providing the field with a more physiologically relevant alternative to traditional immortalized cell lines. Together, these contributions have helped bridge the gap between fundamental stem cell research and applied neuroscience, offering researchers more reliable human-relevant models for studying neurological disease and identifying therapeutic candidates. Falk's work represents an important step toward translating stem cell technologies into practical tools for next-generation drug screening.
Research Focus
Key Achievements
Top Papers
- 1
- 2